• Nolato’s October 29, 2026, third-quarter earnings call featured CEO Anders Bjorklund and CFO Per-Ola Holmstrom.
• Sales rose 7% to SEK 2.5 billion; adjusted EBITDA margin fell to 10.5% from 11.7%.
• Medical Solutions organic sales grew 9%; project ramp-up costs should persist for several quarters but gradually ease.
• Automotive headwinds will persist into the fourth quarter, though management expects no further raw-material pricing drag if current conditions hold.
• Materials delivered 27% organic growth; management expects to sustain margins as the business expands into new segments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nolato AB published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.